[go: up one dir, main page]

ATE73795T1 - Thioformamid-derivate. - Google Patents

Thioformamid-derivate.

Info

Publication number
ATE73795T1
ATE73795T1 AT89300562T AT89300562T ATE73795T1 AT E73795 T1 ATE73795 T1 AT E73795T1 AT 89300562 T AT89300562 T AT 89300562T AT 89300562 T AT89300562 T AT 89300562T AT E73795 T1 ATE73795 T1 AT E73795T1
Authority
AT
Austria
Prior art keywords
thioformamide derivatives
thioformamide
derivatives
oroperties
bioprecursors
Prior art date
Application number
AT89300562T
Other languages
English (en)
Inventor
David Charles Cook
Terance William Hart
Ian Mcfarlane Mclay
Malcolm Norman Palfreyman
Roger John Aitchison Walsh
Jean-Claude Aloup
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Application granted granted Critical
Publication of ATE73795T1 publication Critical patent/ATE73795T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Cold Air Circulating Systems And Constructional Details In Refrigerators (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Cosmetics (AREA)
AT89300562T 1988-01-21 1989-01-20 Thioformamid-derivate. ATE73795T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888801300A GB8801300D0 (en) 1988-01-21 1988-01-21 New compositions of matter
EP89300562A EP0326297B1 (de) 1988-01-21 1989-01-20 Thioformamid-Derivate

Publications (1)

Publication Number Publication Date
ATE73795T1 true ATE73795T1 (de) 1992-04-15

Family

ID=10630288

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89300562T ATE73795T1 (de) 1988-01-21 1989-01-20 Thioformamid-derivate.

Country Status (17)

Country Link
US (1) US4959385A (de)
EP (1) EP0326297B1 (de)
JP (1) JPH01308275A (de)
KR (1) KR890011871A (de)
AT (1) ATE73795T1 (de)
CA (1) CA1335672C (de)
DE (1) DE68900990D1 (de)
DK (1) DK23089A (de)
ES (1) ES2033523T3 (de)
FI (1) FI890293A (de)
GB (1) GB8801300D0 (de)
GR (1) GR3004363T3 (de)
HU (1) HU202517B (de)
NZ (1) NZ227682A (de)
OA (1) OA09032A (de)
PT (1) PT89492B (de)
ZA (1) ZA89479B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276045A (en) * 1989-06-16 1994-01-04 Rhone-Poulenc Sante Thioformamide derivative, process for its preparation, pharmaceutical composition thereof and treatment method
JPH04211048A (ja) * 1990-03-05 1992-08-03 Mitsubishi Kasei Corp チオカルバモイルアセトニトリル誘導体
AU661044B2 (en) * 1991-10-14 1995-07-13 Eisai Co. Ltd. Thioformamide derivative
US5811450A (en) * 1995-11-03 1998-09-22 Gilead Sciences, Inc. Thiepane compounds
KR20010102968A (ko) * 1999-01-07 2001-11-17 후지야마 아키라 시클릭 화합물
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
CN115161672B (zh) * 2022-08-04 2024-04-16 广西师范大学 一种电化学合成氨基(二硫代过氧基)硫代甲酸酯化合物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3206473A (en) * 1962-09-10 1965-09-14 Dow Chemical Co Sulfolanylalkanoic acids and esters thereof
DE3318648A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Substituierte tetrahydrothiopyran-3,5-dion-4-carboxamide
DD250318A1 (de) * 1986-04-29 1987-10-08 Bitterfeld Chemie Verfahren zur herstellung neuer 3,6-dihydro-2h-thiopyran-2-carbonsaeureamide

Also Published As

Publication number Publication date
CA1335672C (en) 1995-05-23
FI890293A (fi) 1989-07-22
US4959385A (en) 1990-09-25
FI890293A0 (fi) 1989-01-19
HU202517B (en) 1991-03-28
DK23089A (da) 1989-07-22
GR3004363T3 (de) 1993-03-31
DE68900990D1 (en) 1992-04-23
GB8801300D0 (en) 1988-02-17
KR890011871A (ko) 1989-08-23
OA09032A (en) 1991-03-31
ZA89479B (en) 1989-10-25
NZ227682A (en) 1991-02-26
HUT49340A (en) 1989-09-28
PT89492A (pt) 1989-10-04
EP0326297B1 (de) 1992-03-18
DK23089D0 (da) 1989-01-19
EP0326297A1 (de) 1989-08-02
JPH01308275A (ja) 1989-12-12
PT89492B (pt) 1994-03-31
ES2033523T3 (es) 1993-03-16

Similar Documents

Publication Publication Date Title
ATE26120T1 (de) Substituierte acyl-derivate von 1,2,3,4tetrahydro-6,7-dimethoxy-3-isoquinolincarbons|ure.
FI906204A (fi) Menetelmä farmaseuttisesti vaikuttavien peptidiyhdisteiden valmistamiseksi
DK0976748T3 (da) Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
DE68926981D1 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung
ATE73795T1 (de) Thioformamid-derivate.
IL85768A (en) Benzoxazine derivatives, their preparation and pharmaceutical compositions containing them
FI911138A (fi) Ny substituerad aminfoerening och foerfarande foer dess framstaellning.
DK0420224T3 (da) Anthihepatopatisk middel
ATE104661T1 (de) Thioformamid-derivate.
ATE105565T1 (de) Pradimicinderivate.
ES2149180T3 (es) Derivado de pirazolotiazolopirimidina.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee